Active Smart Wearable Orthosis for Enhanched Rehabilitation THErapy

NCT ID: NCT03153254

Last Updated: 2018-08-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-09-15

Study Completion Date

2018-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate the usability of a new upper limb robot assisted therapy device in stroke patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The number of physically weak individuals is increasing, resulting in a higher burden on health care and health care workers. The use of robot assisted therapy (RAT) might partly solve this problem. Rehabilitation progress highly depends on training intensity and training duration, favouring the use of RAT.

In this pilot study, the usability of a new upper arm RAT device for upper arm rehabilitation in stroke patients is investigated. Myo-electrical signals will serve as input for the device, assisting the user in flexion and extension of the elbow, which is combined with a stabilizing shoulder brace and a bionic glove.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SEQUENTIAL

Phase 1: Healthy persons Phase 2: Stroke patients
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy persons

Test upper limb robot assisted therapy device. During 1 session of 1/2 hour.

Group Type EXPERIMENTAL

Test upper limb robot assisted therapy device

Intervention Type DEVICE

During 1 session of 1/2 hour.

Stroke patients

Training with new upper limb robot assisted therapy device. During 2 to 5 sessions of 1/2 hour.

Group Type EXPERIMENTAL

Training with new upper limb robot assisted therapy device

Intervention Type DEVICE

During 2 to 5 sessions of 1/2 hour.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Test upper limb robot assisted therapy device

During 1 session of 1/2 hour.

Intervention Type DEVICE

Training with new upper limb robot assisted therapy device

During 2 to 5 sessions of 1/2 hour.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

active orthosis exoskeleton active orthosis exoskeleton

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Persons between 18 and 85 years old that can perform all sorts of daily activities with their upper limbs
* Ability to sit on a chair with adequate trunk stability
* Ability to follow verbal instructions
* Ability to communicate verbally with the researchers


* Stroke patients, more than three months after onset
* Aged between 18 and 85 years
* None to moderate spasticity in the hemiplegic arm (Modified Ashworth Scale: 0-2)
* Detectable voluntary muscle activity at elbow flexion and elbow extension of the hemiplegic arm (Medical research council score: 1-5)
* Ability to sit on a chair with adequate trunk stability
* Ability to follow verbal instructions
* Ability to communicate verbally with the researchers

Exclusion Criteria

* Ever had a fracture in the upper limbs
* Ever had a surgery in the upper limbs
* Pain in the upper limbs obstructing the execution of daily activities with the upper limbs
* Physical trauma in the two months preceding the research
* Mental problems that make the execution of daily activities unreliable
* (Chronic) subluxation of the shoulder joint
* Secundary soft tissue problems which may complicate the research or make it impossible (e.g. shoulder impingement, musculoskeletal problems, sensory deficits)
* Pregnancy
* Pacemaker
* Known allergies for one of the components of the ARTHE rehabilitation tool
2. Stroke patients:


* Stroke patients, less than three months after onset
* Massive spastic patterns
* Severe medical conditions that interfere with the proper execution of the research, patients who are medically unstable
* Cognitive disorders which may complicate the research or make it impossible
* Speaking disorders (aphasia, dysarthria) which may complicate the proper execution of the research and the communication of important verbal information
* Visual disorders which may complicate the research or make it impossible
* (Chronic) subluxation of the shoulder joint
* Shoulder-hand-syndrom
* Pusher syndrom
* Secundary soft tissue problems which may complicate the research or make it impossible (e.g. shoulder impingement, musculoskeletal problems, sensory deficits)
* Pregnancy
* Pacemaker
* Known allergies for one of the components of the ARTHE rehabilitation tool
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ortho-Medico

UNKNOWN

Sponsor Role collaborator

Thomas More Kempen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lieven De Maesschalck

Innovation Manager

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lieven De Maesschalck

Role: PRINCIPAL_INVESTIGATOR

Thomas More Kempen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

RevArthe

Edegem, Antwerp, Belgium

Site Status RECRUITING

Thomas More - Mobilab

Geel, Antwerp, Belgium

Site Status COMPLETED

REVAlution

Herentals, Antwerp, Belgium

Site Status ACTIVE_NOT_RECRUITING

Revalidatie & MS Centrum

Overpelt, Antwerp, Belgium

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lieven De Maesschalck

Role: CONTACT

014/56 23 10 ext. 32

Romy Sels

Role: CONTACT

014/56 23 10 ext. 32

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Christhophe Lafosse, Prof.

Role: primary

Martine Verhoeven

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

S60144

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Evaluation of Robot Assisted Neuro-Rehabilitation
NCT01253018 COMPLETED PHASE1/PHASE2